20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Pneumococcal Vaccine-Naïve Adults 60 Years of Age and Older in Japan, Korea, and Taiwan

NCT04875533 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1425

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumococcal Disease

Interventions

BIOLOGICAL: 20vPnC
OTHER: Saline
BIOLOGICAL: 13vPnC
BIOLOGICAL: PPSV23

Sponsor

Pfizer